Hyperion Defi (HYPD) Operating Margin (2021 - 2026)
Hyperion Defi (HYPD) posted quarterly Operating Margin of 3574.77% for Q1 2026, up 2416371.0% year-over-year from N/an in Q1 2025, and up 144.61% quarter-over-quarter from 8013.49% in Q4 2025.
Hyperion Defi (HYPD) Operating Margin (2021 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Operating Margin for 5 consecutive years, with 3574.77% the latest figure, recorded in Q1 2026.
- In Q1 2026, Operating Margin rose 2416371.0% year-over-year to 3574.77%; the TTM figure through Mar 2026 stood at 3351.68% (up 5853355.0% YoY), while the FY2025 annual figure was 5743.53%, up 7926104.0% from the prior year.
- Operating Margin rose to 3574.77% in Q1 2026 per HYPD's latest filing, from 8013.49% in the prior quarter.
- Across five years, Operating Margin topped out at 3574.77% in Q1 2026 and bottomed at 544255.93% in Q3 2023.
- Historically, Operating Margin has averaged 163393.45% across 4 years, with a median of 60449.77% in 2024.
- Annual changes were most pronounced in 2025 — Operating Margin jumped 45265934 bps — and 2026, when it jumped 2416371 bps.
- Hyperion Defi's Operating Margin stood at 288395.29% in 2023, then surged by 76 bps to 69238.35% in 2024, then surged by 88 bps to 8013.49% in 2025, then soared by 145 bps to 3574.77% in 2026.
- Business Quant data shows HYPD's Operating Margin at 3574.77% in Q1 2026, 8013.49% in Q4 2025, and 1463.84% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 37.40% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.15% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 32.54% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -562.07% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 19.06% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 17.93% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -0.36% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 19.75% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -35.57% |
| 10 | Hyperion Defi | 44.65 Mn | 35.01 Mn | 357,693.00 | 8,668.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8,668.81% |
| Mar 31, 2026 | 3,574.77% |
| Dec 31, 2025 | -8,013.49% |
| Sep 30, 2025 | 1,463.84% |
| Mar 31, 2025 | -20,588.95% |
| Dec 31, 2024 | -69,238.35% |
| Sep 30, 2024 | -451,195.51% |
| Jun 30, 2024 | -51,661.19% |
| Mar 31, 2024 | -205,624.35% |
| Dec 31, 2023 | -288,395.29% |
| Sep 30, 2023 | -544,255.93% |
| Dec 31, 2021 | 30.53% |
| Jun 30, 2021 | -239.11% |
| Mar 31, 2021 | -268.33% |